Granules India to invest in US subsidiaryIllustrative image – not actual.
Pharmaceutical company, Granules India will make an investment of USD 35 million (Rs 220 crore) to expand the operations of Granules Pharmaceuticals Inc, its wholly-owned subsidiary in the US.

The funding will boost the company’s pharmaceutical research & development and manufacturing capacities. The company’s US subsidiary is spread over 1,00,000 sq ft in the Chantilly area of Fairfax County, Virginia.

Granules India aims to expand its global footprint with a firm base and operations in the US. The company will make a total investment of USD 50 million in its US facility. This will help create around 100 new job opportunities.

← All latest storiesBack to top →